Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atragen and Interferon Alfa-2b in Advanced Renal Cell Carcinoma
NCT00003656Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Jan 1999
- Primary completion
- May 2008
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal tretinoin in renal cell carcinoma (RCC), sponsored by Weill Cornell Medicine. Started Jan 1999; status: completed.
02
Drugs
liposomal tretinoin
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00003656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003656.